Senate Approved Historic Legislation Expanding Global AIDS, TB and Malaria Programs

FOR IMMEDIATE RELEASE

CONTACT:
Jennifer Kay
202-789-0801
jennifer@theglobalfight.org

Senate Approved Historic Legislation Expanding Global AIDS, TB and Malaria Programs

Washington D.C., July 17, 2008 – Yesterday, the U.S. Senate approved S. 2731, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, providing $48 billion over the next five years to expand programs to fight the three diseases around the world. The legislation also authorizes $2 billion as a U.S. contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2009 as well as additional funding for the Global Fund’s future growth.

“PEPFAR and the Global Fund have shown that we can make a significant impact in the fight against AIDS, TB and malaria. The Senate has taken an historic step that will dramatically expand this effort and save the lives of millions of children and families around the world,” said

Natasha Bilimoria, Executive Director of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria. “This is a tremendous achievement and we applaud Senators Biden (D-DE), Lugar (R-IN) and Reid (D-NV) for their leadership and commitment to finalize this important legislation. We’d also like to especially thank Senator Durbin (D-IL) for his work in support of the Global Fund.”

Since its creation, the Global Fund has committed over $10 billion to 136 countries around the world to fight AIDS, TB and malaria. Currently, the Global Fund provides about 20 percent of international financing to fight AIDS, two-thirds of international funding for tuberculosis programs and three-quarters of international funding to fight malaria. In just six years, Global Fund programs have put 1.75 million people on lifesaving AIDS treatment, treated 3.9 million people for tuberculosis and distributed 59 million bed nets to protect children and families from malaria. Throughout this time, the Global Fund has remained committed to its founding principles by supporting programs that are country-owned and performance-based while maintaining a strong focus on transparency and accountability of its programs. Along with the PEPFAR program, the Global Fund is translating the hope of access to prevention, treatment and care into reality.

“AIDS, TB and malaria continue to take a terrible toll on millions of people around the world. The expansion of the PEPFAR program and the Global Fund are essential to defeating the most pressing public health challenge of our time,” continued Bilimoria.

Also this week, Congress took steps to fund global HIV/AIDS, TB and malaria programs, including the Global Fund for FY 2009. Both the House and Senate State, Foreign Operations appropriations bills include not less than $600 million for the Global Fund. Earlier this month, the Labor-Health appropriations subcommittees approved an additional $300 million, for a total of at least $900 million as a U.S. contribution to the Global Fund in FY 2009.

FRIENDS OF THE GLOBAL FIGHT

Friends of the Global Fight works to educate, engage and mobilize American decision-makers in the fight to end the worldwide burden of AIDS, tuberculosis and malaria. By focusing these efforts on decision-makers in Washington, Friends seeks to build a sustained commitment to supporting the Global Fund and the fight against the three diseases. For more information about Friends of the Global Fight, visit www.theglobalfight.org.

THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA

The Global Fund is a unique global public/private partnership dedicated to attracting and disbursing additional resources to prevent and treat HIV/AIDS, tuberculosis and malaria. This partnership between governments, civil society, the private sector and affected communities represents a new approach to international health financing. The Global Fund works in close collaboration with other bilateral and multilateral organizations to supplement existing efforts dealing with the three diseases. For more information about the Global Fund, visit www.theglobalfund.org

To download a PDF version please click here.